Alector, Inc.
ALECAlector, Inc. in brief
Alector, Inc. is a listed company in the Biotechnology industry, based in South San Francisco, California, USA. Its market value was $293 M on 21 October 2026, which makes it the 14,879th largest listed company in the world and the 2,898th largest in the USA on this site. It employs about 185 people and Arnon Rosenthal is its chief executive. Its shares trade under the symbol ALEC (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Alector, Inc.
Alector is a Clinical Stage Biopharmaceutical company developing a broad portfolio of programs designed to empower the brains immune system to fight disease. It is having 78 employees as on 2019. The headquarters is in USA.
Alector, Inc. timeline
- 2015
- ✎Renamed Alector, Inc.Formerly Alector LLC.
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2019
- 🔔Initial public offering on NasdaqFinal prospectus filed with the SEC on 7 February 2019; shares registered for exchange trading on 31 January 2019.
- 2021
- 💰Record revenue of $207 millionFY2021, the highest of the 7 years on record.
Events of Alector, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #1,971 (Jan 2020) · #2,014 (Jan 2021) · #2,141 (Jan 2022) · #2,274 (Dec 2022) · #2,635 (Jul 2023) · #2,325 (Jan 2024) · #1,661 (Mar 2026) · #3,051 (Aug 2026) · #2,937 (Oct 2026) · #2,902 (Oct 2026)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- 9.6×
- Free cash flow yield
- -62.8%
- Net margin
- —
- Operating margin
- —
- Return on equity
- -466.3%
- Liabilities / assets
- 89.5%
- Net debt
- $-56M
- Revenue growth
- +3.6%
- R&D / revenue
- 184.9%
- Profit per employee
- $-773 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | — | — | $-156M | $-143M | — |
| Dec 2024 | $101M | +3.6% | $-145M | $-119M | -118.4% |
| Dec 2023 | $97M | -27.3% | $-152M | $-130M | -134.3% |
| Dec 2022 | $134M | -35.5% | $-138M | $-133M | -99.8% |
| Dec 2021 | $207M | +881.4% | $-37M | $-36M | -17.5% |
| Dec 2020 | $21M | -0.6% | $-195M | $-190M | -901.6% |
| Dec 2019 | $21M | -23.3% | $-114M | $-105M | -496.6% |
| Dec 2018 | $28M | — | $-57M | $-52M | -188.8% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-184M | $0M | $-184M | $-1.39 | — |
| Dec 2024 | $-230M | $1M | $-231M | $-1.23 | — |
| Dec 2023 | $-184M | $2M | $-187M | $-1.56 | — |
| Dec 2022 | $-20M | $4M | $-24M | $-1.62 | — |
| Dec 2021 | $299M | $3M | $295M | $-0.45 | — |
| Dec 2020 | $-167M | $5M | $-172M | $-2.45 | — |
| Dec 2019 | $-99M | $15M | $-115M | $-1.71 | — |
| Dec 2018 | $127M | $2M | $126M | $-4.62 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $163M (+4896.0% on a year earlier), net income $125M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 5, 202610-QQuarterly report · period to Sep 2026
- Nov 5, 20268-KCurrent reportResults of operations
- Oct 16, 20268-KCurrent reportMaterial agreement · Other events
- Oct 14, 20268-KCurrent reportDirectors or officers changed
- Oct 5, 20268-KCurrent reportMaterial agreement · Results of operations · Regulation FD disclosure · Other events
- Aug 6, 202610-QQuarterly report · period to Jun 2026
- Aug 6, 20268-KCurrent reportResults of operations
- Jul 8, 20268-KCurrent reportAgreement ended
- Jun 17, 20268-KCurrent reportShareholder vote
- May 7, 20268-KCurrent reportMaterial agreement
- May 7, 202610-QQuarterly report · period to Mar 2026
- May 7, 20268-KCurrent reportResults of operations
Official filings of Alector, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- —
- Operating income
- $-156 M
- Net income
- $-143 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $293 M
- Total liabilities
- $263 M
- Total equity
- $31 M
As of December-2025
Top 100 institutional investors in Alector, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BVF Inc/il | 10,046,206 | New | 6.75% | $19 M | Nov 16, 2026 |
| 2 | TCG Crossover Management, LLC | 10,000,000 | 0 (0.00%) | 6.72% | $19 M | Nov 16, 2026 |
| 3 | BlackRock, Inc. | 7,699,215 | -148,664 (-1.89%) | 5.17% | $14 M | Nov 13, 2026 |
| 4 | Acadian Asset Management LLC | 4,461,590 | +47,245 (+1.07%) | 3.00% | $8 M | Nov 9, 2026 |
| 5 | Nantahala Capital Management, LLC | 4,318,109 | -4,318,109 (-50.00%) | 2.90% | $8 M | Nov 13, 2026 |
| 6 | Kynam Capital Management, LP | 4,308,494 | +500,000 (+13.13%) | 2.89% | $8 M | Nov 16, 2026 |
| 7 | Vanguard Capital Management LLC | 4,010,540 | +1,200 (+0.03%) | 2.69% | $7 M | Nov 13, 2026 |
| 8 | Merck & Co., Inc. | 3,545,719 | 0 (0.00%) | 2.38% | $7 M | Nov 13, 2026 |
| 9 | Millennium Management LLC | 3,045,946 | +1,057,111 (+53.15%) | 2.05% | $6 M | Nov 16, 2026 |
| 10 | Vanguard Portfolio Management LLC | 2,677,738 | -142,755 (-5.06%) | 1.80% | $5 M | Nov 13, 2026 |
| 11 | D. E. Shaw & Co., Inc. | 2,632,288 | -327,695 (-11.07%) | 1.77% | $5 M | Nov 16, 2026 |
| 12 | ADAR1 Capital Management, LLC | 2,514,840 | -368,743 (-12.79%) | 1.69% | $5 M | Nov 16, 2026 |
| 13 | Geode Capital Management, LLC | 2,477,460 | +23,189 (+0.94%) | 1.66% | $5 M | Nov 6, 2026 |
| 14 | 683 Capital Management, LLC | 2,410,000 | -790,000 (-24.69%) | 1.62% | $4 M | Nov 16, 2026 |
| 15 | Spruce Street Capital LP | 2,101,068 | 0 (0.00%) | 1.41% | $4 M | Nov 13, 2026 |
| 16 | Ikarian Capital, LLC | 1,982,606 | 0 (0.00%) | 1.33% | $4 M | Nov 16, 2026 |
| 17 | State Street Corp | 1,825,820 | -53,945 (-2.87%) | 1.23% | $3 M | Nov 12, 2026 |
| 18 | Medici Capital LLC | 1,652,520 | 0 (0.00%) | 1.11% | $3 M | Nov 10, 2026 |
| 19 | Mackenzie Financial Corp | 1,461,163 | +351,393 (+31.66%) | 0.98% | $3 M | Nov 2, 2026 |
| 20 | Eversept Partners, LP | 1,418,233 | -5,640 (-0.40%) | 0.95% | $3 M | Nov 16, 2026 |
| 21 | Jacobs Levy Equity Management, Inc | 1,391,846 | -374,083 (-21.18%) | 0.93% | $3 M | Nov 16, 2026 |
| 22 | Euclidean Capital LLC | 1,307,858 | 0 (0.00%) | 0.88% | $2 M | Nov 16, 2026 |
| 23 | Deutsche Bank AG\ | 1,068,063 | -30,325 (-2.76%) | 0.72% | $2 M | Nov 6, 2026 |
| 24 | Deerfield Management Company, L.P. | 1,055,192 | 0 (0.00%) | 0.71% | $2 M | Nov 16, 2026 |
| 25 | Renaissance Technologies LLC | 1,011,149 | +75,983 (+8.13%) | 0.68% | $2 M | Nov 12, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Marshall Wace, LLP | 973,761 | +375,202 (+62.68%) | 0.65% | $2 M | Nov 13, 2026 |
| 27 | Elmind Capital, LP | 915,902 | +15,902 (+1.77%) | 0.62% | $2 M | Nov 16, 2026 |
| 28 | Panagora Asset Management Inc | 913,403 | +67,404 (+7.97%) | 0.61% | $2 M | Nov 12, 2026 |
| 29 | DAFNA Capital Management LLC | 908,351 | 0 (0.00%) | 0.61% | $2 M | Nov 16, 2026 |
| 30 | Two Sigma Investments, LP | 897,844 | -147,532 (-14.11%) | 0.60% | $2 M | Nov 16, 2026 |
| 31 | AQR Capital Management LLC | 894,091 | -415,486 (-31.73%) | 0.60% | $2 M | Nov 16, 2026 |
| 32 | Charles Schwab Investment Management Inc | 882,134 | +63,303 (+7.73%) | 0.59% | $2 M | Nov 16, 2026 |
| 33 | Goldman Sachs Group Inc | 791,601 | +357,726 (+82.45%) | 0.53% | $1 M | Nov 16, 2026 |
| 34 | Northern Trust Corp | 756,139 | -17,323 (-2.24%) | 0.51% | $1 M | Nov 16, 2026 |
| 35 | Vanguard Fiduciary Trust Co | 657,018 | -6,574 (-0.99%) | 0.44% | $1 M | Nov 13, 2026 |
| 36 | Boothbay Fund Management, LLC | 532,850 | 0 (0.00%) | 0.36% | $1 M | Nov 16, 2026 |
| 37 | LMR Partners LLP | 450,000 | +250,000 (+125.00%) | 0.30% | $1 M | Nov 16, 2026 |
| 38 | XTX Topco Ltd | 257,280 | -142,401 (-35.63%) | 0.17% | $0 M | Nov 16, 2026 |
| 39 | Invesco Ltd. | 256,379 | -760 (-0.30%) | 0.17% | $0 M | Nov 12, 2026 |
| 40 | Bank of New York Mellon Corp | 251,966 | +1,873 (+0.75%) | 0.17% | $0 M | Nov 5, 2026 |
| 41 | Balyasny Asset Management L.P. | 244,780 | -3,002,646 (-92.46%) | 0.16% | $0 M | Nov 16, 2026 |
| 42 | Citadel Advisors LLC | 231,022 | -160,210 (-40.95%) | 0.16% | $0 M | Nov 16, 2026 |
| 43 | Bank Of America Corp /de/ | 221,722 | +79,044 (+55.40%) | 0.15% | $0 M | Nov 16, 2026 |
| 44 | UBS Group AG | 193,426 | -80,354 (-29.35%) | 0.13% | $0 M | Nov 10, 2026 |
| 45 | Nuveen, LLC | 191,369 | +15,135 (+8.59%) | 0.13% | $0 M | Nov 10, 2026 |
| 46 | Ameriprise Financial Inc | 187,420 | -37,110 (-16.53%) | 0.13% | $0 M | Nov 16, 2026 |
| 47 | Nano Cap New Millennium Growth Fund L P | 180,000 | -20,000 (-10.00%) | 0.12% | $0 M | Nov 13, 2026 |
| 48 | Utah Retirement Systems | 174,862 | +20,572 (+13.33%) | 0.12% | $0 M | Nov 16, 2026 |
| 49 | Strs Ohio | 139,900 | +38,300 (+37.70%) | 0.09% | $0 M | Oct 30, 2026 |
| 50 | Morgan Stanley | 123,515 | +3,035 (+2.52%) | 0.08% | $0 M | Nov 13, 2026 |
| 51 | Cantor Fitzgerald, L. P. | 120,000 | -470,984 (-79.69%) | 0.08% | $0 M | Nov 16, 2026 |
| 52 | Bridgeway Capital Management, LLC | 115,000 | -27,500 (-19.30%) | 0.08% | $0 M | Nov 16, 2026 |
| 53 | Empowered Funds, LLC | 115,000 | New | 0.08% | $0 M | Nov 13, 2026 |
| 54 | SEI Investments Co | 109,558 | +38,407 (+53.98%) | 0.07% | $0 M | Nov 10, 2026 |
| 55 | Alliancebernstein L.P. | 108,940 | 0 (0.00%) | 0.07% | $0 M | Nov 16, 2026 |
| 56 | Russell Investments Group, Ltd. | 106,614 | +8,118 (+8.24%) | 0.07% | $0 M | Nov 6, 2026 |
| 57 | Rhumbline Advisers | 105,281 | -4,251 (-3.88%) | 0.07% | $0 M | Nov 10, 2026 |
| 58 | Employees Retirement System of Texas | 99,803 | New | 0.07% | $0 M | Nov 10, 2026 |
| 59 | Canada Pension Plan Investment Board | 93,000 | -38,300 (-29.17%) | 0.06% | $0 M | Nov 16, 2026 |
| 60 | Jasper Ridge Partners, L.P. | 89,457 | +15,926 (+21.66%) | 0.06% | $0 M | Nov 13, 2026 |
| 61 | Price T Rowe Associates Inc /MD/ | 81,655 | 0 (0.00%) | 0.05% | $0 M | Nov 16, 2026 |
| 62 | HSBC Holdings PLC | 73,525 | +25,002 (+51.53%) | 0.05% | $0 M | Nov 16, 2026 |
| 63 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 69,666 | 0 (0.00%) | 0.05% | $0 M | Nov 16, 2026 |
| 64 | Los Angeles Capital Management LLC | 67,837 | New | 0.05% | $0 M | Nov 12, 2026 |
| 65 | Barclays PLC | 66,500 | +21,543 (+47.92%) | 0.04% | $0 M | Nov 6, 2026 |
| 66 | Public Employees Retirement System Of Ohio | 62,602 | -57,167 (-47.73%) | 0.04% | $0 M | Nov 16, 2026 |
| 67 | Point72 Asset Management, L.P. | 57,637 | +30,938 (+115.88%) | 0.04% | $0 M | Nov 16, 2026 |
| 68 | Vanguard Personalized Indexing Management, LLC | 47,672 | -1,773 (-3.59%) | 0.03% | $0 M | Nov 16, 2026 |
| 69 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 47,580 | +2,390 (+5.29%) | 0.03% | $0 M | Nov 16, 2026 |
| 70 | Jpmorgan Chase & Co | 47,212 | +4,214 (+9.80%) | 0.03% | $0 M | Nov 12, 2026 |
| 71 | Tudor Investment Corp Et Al | 40,356 | New | 0.03% | $0 M | Nov 16, 2026 |
| 72 | MetLife Investment Management, LLC | 36,589 | -22,107 (-37.66%) | 0.02% | $0 M | Nov 16, 2026 |
| 73 | Quadrature Capital Ltd | 34,862 | +20,693 (+146.04%) | 0.02% | $0 M | Nov 13, 2026 |
| 74 | BNP Paribas Financial Markets | 34,472 | +13,272 (+62.60%) | 0.02% | $0 M | Nov 12, 2026 |
| 75 | Verdad Advisers, LP | 31,909 | -28,600 (-47.27%) | 0.02% | $0 M | Nov 16, 2026 |
| 76 | Vanguard Global Advisers, LLC | 31,756 | +454 (+1.45%) | 0.02% | $0 M | Nov 13, 2026 |
| 77 | Cannell & Spears LLC | 30,320 | -22 (-0.07%) | 0.02% | $0 M | Nov 12, 2026 |
| 78 | Dynamic Technology Lab Private Ltd | 29,958 | New | 0.02% | $0 M | Nov 13, 2026 |
| 79 | Walleye Capital LLC | 29,142 | New | 0.02% | $0 M | Nov 13, 2026 |
| 80 | Wells Fargo & Company/mn | 27,440 | -61,732 (-69.23%) | 0.02% | $0 M | Nov 16, 2026 |
| 81 | Manufacturers Life Insurance Company, The | 25,804 | +6,407 (+33.03%) | 0.02% | $0 M | Nov 13, 2026 |
| 82 | Police & Firemen's Retirement System of New Jersey | 23,426 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 83 | Citigroup Inc | 22,824 | -23,451 (-50.68%) | 0.02% | $0 M | Nov 4, 2026 |
| 84 | Prudential Financial Inc | 22,315 | +6,300 (+39.34%) | 0.01% | $0 M | Nov 16, 2026 |
| 85 | Ieq Capital, LLC | 22,078 | -38,492 (-63.55%) | 0.01% | $0 M | Nov 10, 2026 |
| 86 | Voya Investment Management LLC | 21,898 | 0 (0.00%) | 0.01% | $0 M | Nov 10, 2026 |
| 87 | Axq Capital, LP | 20,328 | New | 0.01% | $0 M | Nov 12, 2026 |
| 88 | Susquehanna Portfolio Strategies, LLC | 14,371 | New | 0.01% | $0 M | Nov 16, 2026 |
| 89 | FMR LLC | 13,923 | -1,382,475 (-99.00%) | 0.01% | $0 M | Nov 10, 2026 |
| 90 | Mariner, LLC | 13,831 | -38,878 (-73.76%) | 0.01% | $0 M | Nov 12, 2026 |
| 91 | Neuberger Berman Group LLC | 13,073 | -448 (-3.31%) | 0.01% | $0 M | Nov 13, 2026 |
| 92 | Bronte Capital Management Pty Ltd. | 11,758 | 0 (0.00%) | 0.01% | $0 M | Nov 12, 2026 |
| 93 | ProShare Advisors LLC | 11,693 | -1,155 (-8.99%) | 0.01% | $0 M | Oct 29, 2026 |
| 94 | Susquehanna International Group, LLP | 10,999 | -13,124 (-54.40%) | 0.01% | $0 M | Nov 16, 2026 |
| 95 | Principal Financial Group Inc | 10,919 | New | 0.01% | $0 M | Nov 2, 2026 |
| 96 | Cerity Partners LLC | 10,454 | -22,067 (-67.85%) | 0.01% | $0 M | Nov 13, 2026 |
| 97 | New York State Common Retirement Fund | 10,310 | 0 (0.00%) | 0.01% | $0 M | Nov 17, 2026 |
| 98 | Commonwealth Equity Services, LLC | 10,300 | New | 0.01% | $0 M | Nov 2, 2026 |
| 99 | Blackstone Inc. | 10,286 | -66,859 (-86.67%) | 0.01% | $0 M | Nov 16, 2026 |
| 100 | HighTower Advisors, LLC | 10,001 | -226 (-2.21%) | 0.01% | $0 M | Nov 10, 2026 |
Mutual funds holding Alector, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 2.84 M | $6 M | 1.9% | <0.01% | +12% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 2.55 M | $5 M | 1.7% | <0.01% | +17% | Jun 30, 2026 |
| 🇺🇸 Select Biotechnology PortfolioFidelity Management & Research Company LLC | 1.38 M | $3 M | 0.93% | 0.06% | −38% | May 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 1.03 M | $2 M | 0.69% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 820,921 | $2 M | 0.55% | 0.01% | +1452% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 1.07 M | $2 M | 0.72% | <0.01% | +19% | Jul 31, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 635,411 | $1 M | 0.43% | 0.03% | −1.2% | May 29, 2026 |
| 🇺🇸 Vanguard Strategic Small-Cap Equity FundThe Vanguard Group, Inc. | 628,627 | $1 M | 0.42% | 0.04% | no change | Jun 30, 2026 |
| 🇺🇸 Small Company Growth PortfolioThe Vanguard Group, Inc. | 615,923 | $1 M | 0.41% | 0.07% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 484,110 | $1 M | 0.33% | <0.01% | −1.6% | May 31, 2026 |
| 🇺🇸 Vanguard Explorer FundThe Vanguard Group, Inc. | 673,493 | $1 M | 0.45% | <0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 468,899 | $1 M | 0.31% | <0.01% | +18% | May 31, 2026 |
| 🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc. | 441,696 | $1 M | 0.30% | <0.01% | −1.6% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 330,159 | $1 M | 0.22% | 0.04% | +44% | Jun 30, 2026 |
| 🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc. | 229,241 | $0 M | 0.15% | <0.01% | −5.1% | May 31, 2026 |
| 🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I | 228,555 | $0 M | 0.15% | 0.04% | −22% | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 195,896 | $0 M | 0.13% | <0.01% | +50% | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 239,291 | $0 M | 0.16% | <0.01% | +20% | Jul 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 163,064 | $0 M | 0.11% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors | 161,266 | $0 M | 0.11% | <0.01% | −77% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 139,461 | $0 M | 0.09% | <0.01% | +6.0% | May 31, 2026 |
| 🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS | 149,514 | $0 M | 0.10% | 0.07% | no change | Jun 30, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 142,500 | $0 M | 0.10% | 0.19% | no change | Jun 30, 2026 |
| 🇺🇸 Clearwater Select Equity FundClearwater Management Co Inc. | 137,679 | $0 M | 0.09% | 0.05% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS | 133,398 | $0 M | 0.09% | 0.12% | −13% | Jun 30, 2026 |
| 🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC | 154,955 | $0 M | 0.10% | <0.01% | −5.9% | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 104,277 | $0 M | 0.07% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 129,532 | $0 M | 0.09% | <0.01% | +20% | Jul 31, 2026 |
| 🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC | 95,409 | $0 M | 0.06% | 0.02% | −51% | Jun 30, 2026 |
| 🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc. | 87,957 | $0 M | 0.06% | <0.01% | new | May 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 81,599 | $0 M | 0.05% | 0.01% | +1296% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 64,157 | $0 M | 0.04% | 0.01% | +18% | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 61,781 | $0 M | 0.04% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 59,889 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 57,570 | $0 M | 0.04% | <0.01% | +16% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 53,202 | $0 M | 0.04% | <0.01% | +114% | Jun 30, 2026 |
| 🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC | 70,637 | $0 M | 0.05% | 0.04% | −4.0% | Jul 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 52,271 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 51,120 | $0 M | 0.03% | <0.01% | +15% | Jun 30, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 47,602 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 44,880 | $0 M | 0.03% | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 39,565 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 38,500 | $0 M | 0.03% | <0.01% | −14% | May 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC | 39,925 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 50,000 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 46,882 | $0 M | 0.03% | <0.01% | +19% | Jul 31, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 46,002 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 33,621 | $0 M | 0.02% | <0.01% | +12% | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 33,431 | $0 M | 0.02% | <0.01% | +78% | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 42,752 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 30,935 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Tiff Multi-Asset FundTIFF Advisory Services, LLC | 29,281 | $0 M | 0.02% | <0.01% | +3.5% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P. | 38,173 | $0 M | 0.03% | 0.02% | new | Jul 31, 2026 |
| 🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors | 27,500 | $0 M | 0.02% | <0.01% | −24% | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 32,930 | $0 M | 0.02% | <0.01% | −2.1% | Jul 31, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 24,147 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 22,207 | $0 M | 0.01% | 0.02% | +46% | Jun 30, 2026 |
| 🇺🇸 Vanguard Growth And Income FundWellington Management Company LLP | 21,502 | $0 M | 0.01% | <0.01% | −51% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 18,766 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 17,125 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 16,220 | $0 M | 0.01% | <0.01% | −0.8% | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 16,049 | $0 M | 0.01% | <0.01% | +75% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC | 15,909 | $0 M | 0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 15,330 | $0 M | 0.01% | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 14,968 | $0 M | 0.01% | <0.01% | +88% | Jun 30, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 14,249 | $0 M | <0.01% | <0.01% | +42% | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 13,000 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 12,826 | $0 M | <0.01% | <0.01% | +721% | Jun 30, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 12,600 | $0 M | <0.01% | <0.01% | −3.8% | Jun 30, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 14,016 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 13,145 | $0 M | <0.01% | <0.01% | −24% | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 9,390 | $0 M | <0.01% | <0.01% | −37% | Jun 30, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 12,087 | $0 M | <0.01% | <0.01% | +49% | Jul 31, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 8,175 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 7,803 | $0 M | <0.01% | 0.01% | +2527% | Jun 30, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 7,649 | $0 M | <0.01% | <0.01% | +41% | Jun 30, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 6,846 | $0 M | <0.01% | <0.01% | +9.3% | Jun 30, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 9,070 | $0 M | <0.01% | <0.01% | +5.9% | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 6,602 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 6,129 | $0 M | <0.01% | <0.01% | +3.3% | May 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 8,494 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 7,735 | $0 M | <0.01% | <0.01% | −18% | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 5,223 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC | 5,468 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 6,690 | $0 M | <0.01% | <0.01% | +954% | Jul 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 4,662 | $0 M | <0.01% | <0.01% | +178% | Jun 30, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 4,283 | $0 M | <0.01% | <0.01% | +23% | May 31, 2026 |
| 🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS | 5,343 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC | 3,697 | $0 M | <0.01% | <0.01% | −70% | Jun 30, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 3,385 | $0 M | <0.01% | <0.01% | −32% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 3,348 | $0 M | <0.01% | <0.01% | −33% | May 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 3,260 | $0 M | <0.01% | <0.01% | −19% | Jun 30, 2026 |
| 🇺🇸 AZL DFA U.S. Core Equity FundAllianz Investment Management LLC | 3,000 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 3,867 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 2,403 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 2,341 | $0 M | <0.01% | <0.01% | −5.1% | May 31, 2026 |
| 🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC | 2,538 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC | 2,499 | $0 M | <0.01% | <0.01% | −34% | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 2,385 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 2,986 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Alector, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Grace Wong-SaradPrincipal Accounting Officer | Grant or award | +55,555 | — | — | 161,570 | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Grant or award | +44,567 | — | — | 395,216 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Grant or award | +217,500 | — | — | 2.51 M | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -3,625 | $2.510 | $9 K | 106,015 | Form 4 |
| filed | Arnon RosenthalChief Executive Officer, Director | Sell | -72,606 | $2.660 | $193 K | 2.29 M | Form 4 |
| filed | Neil Lindsay BerkleyCFO & Chief Business Officer | Sell | -29,251 | $2.660 | $78 K | 350,649 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell | -5,165 | $2.670 | $14 K | 109,640 | Form 4 |
| filed | Grace Wong-SaradPrincipal Accounting Officer | Sell10b5-1 plan | -656 | $2.750 | $2 K | 114,805 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Alector, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-10-21 20:01 UTC, code T3, resumed 20:35 UTC
Fails to deliver
- : 3,500 shares at $1.97
- : 341 shares at $1.87
- : 175,169 shares at $2.08
- : 1,500 shares at $2.02
- : 39,070 shares at $1.92
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Alector, Inc. scorecard#
Passes 4 of the 12 checks that could be worked out: strongest in financial health (3 of 4), weakest in profitability (0 of 3). Fiscal year 2025; market cap of Oct 21, 2026.
Valuation0 of 2
- –P/E below its peers' medianNo P/E on file.
- ✗Price to book below its peers' median9.6×Price to book 9.6× against Biotechnology's median of 2.9×.
- –Price to sales below its peers' medianNo Price to sales on file.
- ✗Free cash flow yield above 5%-62.8%Free cash flow is -62.8% of the market value.
- –Earnings yield above the 10-year Treasury yieldNo P/E on file.
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth1 of 2
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-1.39 vs -1.23Diluted EPS -1.39 in fiscal 2025 against -1.23 the year before (report's currency).
- ✓Net income higher than five years earlier-$143 M-$143 M in fiscal 2025 against -$190 M in 2020.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 3
- ✗Profitable in the newest year-$143 MNet income -$143 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- –Operating margin above its peers' medianNo operating margin on file.
- ✗Return on equity above 15%-181.6%-181.6% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health3 of 4
- ✓Short-term assets cover short-term liabilities3.8×Current ratio 3.83 at the end of fiscal 2025.
- ✓Debt below equity0.3×Debt to equity 0.33 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $56 M at the end of fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year6.6%Diluted shares up 6.6% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Alector, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 21−79.1%100% | 101r101+3.6%100% | 97r97−27.3%100% | 134r134−35.5%100% | 207+882%100% | 21−0.6%100% | 21−23.3%100% | 28+641%100% | 3.7—100% | |
| Research and development | 123−33.8%585% | 186−3.2%185% | 192−8.7%198% | 210+11.1%157% | 189+20.7%91.5% | 157+56.0%744% | 101+37.7%474% | 73+144%264% | 30—801% | |
| General and administrative | 54−9.4%257% | 60+5.2%59.3% | 57−7.1%58.4% | 61+10.9%45.7% | 55−7.3%26.6% | 59+69.3%282% | 35+194%165% | 12+83.5%43.1% | 6.5—174% | |
| Operating expenses | 177−27.9%841% | 246−1.3%244% | 249−8.3%256% | 271+11.0%203% | 244+13.0%118% | 216+59.5%1025% | 136+59.6%639% | 85+133%307% | 36—975% | |
| Operating income | −156—−741% | −145—−144% | −152—−156% | −138—−103% | −37—−18.0% | −195—−925% | −114—−539% | −57—−207% | −33—−875% | |
| Other non-operating income (expense) | 13−49.2%62.9% | 26−1.8%25.9% | 27+241%27.4% | 7.8+654%5.8% | 1.0−79.2%0.5% | 4.9−45.2%23.4% | 9.0+78.9%42.5% | 5.0+2433%18.2% | 0.2—5.3% | |
| Income before tax | −143—−678% | −119r−119—−118% | −125—−129% | −130—−97.4% | — | — | — | — | — | |
| Income tax | 0.2+31.3%0.8% | 0.1−97.5%0.1% | 5.2+60.2%5.4% | 3.3—2.4% | 0—0.0% | 0—0.0% | 0—0.0% | — | — | |
| Net income including minority interests | −143—−679% | −119—−118% | −130—−134% | −133—−99.8% | −36—−17.5% | −190—−902% | −105—−497% | −52—−189% | −32—−870% | |
| Net income attributable to shareholders | −143—−679% | −119—−118% | −130—−134% | −133—−99.8% | −36—−17.5% | −190—−902% | −105—−497% | −52—−189% | −32—−870% | |
| Earnings per share, basic | -1.39—— | -1.23—— | -1.56—— | -1.62—— | -0.45—— | -2.45—— | -1.71—— | -4.62—— | -3.55—— | |
| Earnings per share, diluted | -1.39—— | -1.23—— | -1.56—— | -1.62—— | -0.45—— | -2.45—— | -1.71—— | -4.62—— | -3.55—— | |
| Shares, weighted average (basic) | 103+6.6%— | 97+15.4%— | 84+1.5%— | 82+2.6%— | 80+3.4%— | 78—— | — | — | — | |
| Shares, weighted average (diluted) | 103+6.6%— | 97+15.4%— | 84+1.5%— | 82+2.6%— | 80+3.4%— | 78+26.0%— | 62+446%— | 11+23.6%— | 9.1—— | |
| Balance sheet | ||||||||||
| Cash and cash equivalents | 66+99.3%22.4% | 33−55.7%7.1% | 75−51.7%12.0% | 154−53.1%19.6% | 329+559%40.4% | 50−44.3%10.2% | 90+36.9%21.2% | 65+102%21.2% | 32—— | |
| Short-term investments | 190−50.0%64.9% | 380−19.8%81.2% | 474−15.1%76.3% | 559+37.5%70.9% | 406+11.8%49.8% | 363+37.9%74.4% | 263+17.1%62.4% | 225—72.9% | — | |
| Other current assets | 10−8.7%3.6% | 11−32.6%2.4% | 17+54.1%2.7% | 11+55.5%1.4% | 7.1−13.8%0.9% | 8.2+88.0%1.7% | 4.4+57.7%1.0% | 2.8—0.9% | — | |
| Current assets | 266−37.3%90.9% | 425−24.9%90.7% | 566−22.1%91.0% | 726−3.1%92.2% | 750+77.9%92.0% | 422+17.9%86.3% | 357+21.9%84.7% | 293—95.1% | — | |
| Property, plant and equipment | 11−36.8%3.7% | 17−21.6%3.7% | 22−14.3%3.5% | 26−6.6%3.2% | 27−9.4%3.4% | 30−10.8%6.2% | 34+210%8.0% | 11—3.5% | — | |
| Right-of-use (leased) assets | 14−31.3%4.7% | 20−20.8%4.3% | 25−9.4%4.1% | 28−9.0%3.5% | 31−5.9%3.8% | 32+14.0%6.7% | 28—6.7% | — | — | |
| Total assets | 293−37.4%100% | 468−24.7%100% | 622−21.1%100% | 788−3.3%100% | 815+66.9%100% | 488+15.7%100% | 422+36.8%100% | 308—100% | — | |
| Accounts payable | 1.7−23.7%0.6% | 2.2−41.3%0.5% | 3.8−9.9%0.6% | 4.2−11.8%0.5% | 4.7+58.1%0.6% | 3.0+981%0.6% | 0.3+121%0.1% | 0.1—0.0% | — | |
| Debt due within a year | 0.4—0.1% | — | — | — | — | — | — | — | — | |
| Current liabilities | 70−44.4%23.7% | 125−29.7%26.7% | 178+89.7%28.6% | 94−32.8%11.9% | 140+105%17.1% | 68+9.9%13.9% | 62+29.2%14.7% | 48—15.5% | — | |
| Long-term debt | 9.3−0.7%3.2% | 9.4—2.0% | 0—0.0% | — | — | — | — | — | — | |
| Lease liabilities (non-current) | 17−28.3%6.0% | 24−20.0%5.2% | 30−13.6%4.9% | 35−11.4%4.5% | 40−9.0%4.9% | 44+5.5%9.0% | 41—9.8% | — | — | |
| Total liabilities | 263−23.1%89.5% | 342−30.0%72.9% | 488−14.9%78.4% | 573+11.5%72.8% | 514+133%63.1% | 221−2.8%45.2% | 227+16.4%53.8% | 195—63.3% | — | |
| Retained earnings | −972—−331% | −829—−177% | −710—−114% | −580—−73.6% | −446—−54.8% | −410—−84.0% | −220—−52.1% | −114—−37.1% | — | |
| Shareholders' equity | 31−75.8%10.5% | 127−5.5%27.1% | 134−37.4%21.6% | 214−28.7%27.2% | 301+12.4%36.9% | 268+37.4%54.8% | 195—46.2% | −97—−31.6% | −52—— | |
| Total liabilities and equity | 293−37.4%100% | 468−24.7%100% | 622−21.1%100% | 788−3.3%100% | 815+66.9%100% | 488+15.7%100% | 422+36.8%100% | 308—100% | — | |
| Shares outstanding | 110+11.4%— | 99+16.7%— | 85+2.4%— | 83r82+1.1%— | 82r79+3.4%— | 79+14.9%— | 69+402%— | 14—— | — | |
| Cash-flow statement | ||||||||||
| Depreciation and amortization | 5.7+5.8%27.2% | 5.4−5.6%5.4% | 5.7+0.2%5.9% | 5.7−9.7%4.3% | 6.3+7.8%3.1% | 5.9+55.5%27.8% | 3.8+270%17.8% | 1.0+49.9%3.7% | 0.7—18.2% | |
| Share-based compensation | 27−32.4%127% | 39−7.8%39.2% | 43−7.3%44.1% | 46+13.1%34.5% | 41+33.6%19.7% | 31+87.5%145% | 16+135%76.7% | 6.9+29.3%25.0% | 5.4—143% | |
| Cash from operating activities | −184—−874% | −230—−229% | −184—−190% | −20−107%−15.2% | 299—144% | −167—−790% | −99−178%−468% | 127—461% | −18—−476% | |
| Capital expenditure | −0.0—−0.2% | −1.3—−1.2% | −2.4—−2.5% | −4.1—−3.1% | −3.2—−1.6% | −5.0—−23.9% | −15—−71.9% | −1.9—−6.8% | −0.8—−21.4% | |
| Cash from investing activities | 197+83.5%934% | 107+5.1%107% | 102—105% | −159—−119% | −50—−24.0% | −105—−498% | −49—−230% | −224—−810% | −0.8—−21.4% | |
| Shares issued | 20−71.9%95.0% | 71—70.7% | — | — | — | — | — | — | — | |
| Cash from financing activities | 20−75.2%96.1% | 82+3098%81.1% | 2.6−43.5%2.6% | 4.5−85.1%3.4% | 30−86.9%14.6% | 232+34.7%1100% | 172+31.4%812% | 131—474% | −0.0—−0.4% | |
| Change in cash | 33—156% | −41—−41.0% | −80—−82.1% | −175−163%−131% | 279—135% | −40−264%−188% | 24−29.9%114% | 34—125% | −19—−498% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 173+151%100% | 163+4896%100% | 3.3−57.8%100% | 1.0−71.7%100% | 6.2*−88.5%100% | 3.3−78.8%100% | 7.9−47.8%100% | 3.7−76.7%100% | 54r54*+257%100% | 15—100% | 15—100% | 16r16—100% | 15*—100% | |
| Research and development | 100−27.2%57.5% | 30+2.3%18.4% | 19−29.5%586% | 18−46.9%1707% | 32*−30.1%520% | 29−38.9%900% | 28−40.4%351% | 34−25.5%909% | 46*−2.6%85.7% | 48—313% | 46—307% | 45—284% | 48*—314% | |
| General and administrative | 39−30.5%22.3% | 9.0−21.9%5.5% | 8.3−42.7%249% | 8.1−44.9%775% | 13*−11.2%214% | 12−27.0%353% | 14+0.2%183% | 15+2.0%398% | 15*+0.7%27.7% | 16—103% | 14—95.3% | 14—90.8% | 15*—98.2% | |
| Operating expenses | 139−28.1%79.8% | 39−4.5%24.0% | 28−34.0%835% | 26−46.3%2482% | 46*−25.5%734% | 41−35.9%1254% | 42−30.8%534% | 48−18.8%1307% | 61*−1.8%113% | 64—416% | 61—402% | 60—375% | 63*—412% | |
| Operating income | 35—20.2% | 124—76.0% | −24—−735% | −25—−2382% | −40*—−634% | −38—−1154% | −34—−434% | −45—−1208% | −7.2*—−13.4% | −48—−316% | −46—−302% | −44—−275% | −47*—−312% | |
| Other non-operating income (expense) | 6.8−57.5%3.9% | 0.8−72.2%0.5% | 1.5−57.6%46.2% | 2.0−52.9%190% | 2.5*−52.8%39.6% | 2.9−52.7%90.2% | 3.6−48.4%45.9% | 4.2−44.7%114% | 5.2*−32.0%9.6% | 6.2—40.5% | 7.0—46.4% | 7.6—48.0% | 7.7*—50.6% | |
| Income before tax | 42—24.1% | 125—76.5% | −23—−689% | −23—−2192% | −37*—−595% | −35—−1063% | −31—−388% | −40r−41—−1094% | −2.0r−2.0*—−3.7% | −42—−275% | −39—−256% | −36—−227% | — | |
| Income tax | 0.4+646%0.2% | 0.1—0.0% | 0.1—3.9% | 0—0.0% | 0.2*+250%2.7% | 0—0.0% | 0−100%0.0% | 0−100%0.0% | 0.0*−97.1%0.1% | 0—0.0% | 0.1—0.5% | 0.0—0.0% | 1.7*—11.0% | |
| Net income including minority interests | 41—23.9% | 125*—76.5% | −23*—−692% | −23—−2192% | −37*—−598% | −35*—−1063% | −31*—−388% | −40—−1094% | −2.1*—−3.8% | −42*—−275% | −39*—−256% | −36—−227% | −41*—−273% | |
| Net income attributable to shareholders | 41—23.9% | 125—76.5% | −23—−692% | −23—−2192% | −37*—−598% | −35—−1063% | −31—−388% | −40—−1094% | −2.1*—−3.8% | −42—−275% | −39—−256% | −36—−227% | −41*—−273% | |
| Earnings per share, basic | — | 1.11—— | -0.21—— | -0.21—— | — | -0.34—— | -0.30—— | -0.41—— | — | -0.43—— | -0.40—— | -0.38—— | — | |
| Earnings per share, diluted | — | 1.11—— | -0.21—— | -0.21—— | — | -0.34—— | -0.30—— | -0.41—— | — | -0.43—— | -0.40—— | -0.38—— | — | |
| Shares, weighted average (basic) | 112+9.0%— | 112+9.0%— | 111+10.8%— | 111+11.3%— | — | 103+5.2%— | 100+3.8%— | 99+6.0%— | — | 98—— | 97—— | 94—— | — | |
| Shares, weighted average (diluted) | 112+9.6%— | 112+9.6%— | 111+10.8%— | 111+11.3%— | — | 103+5.2%— | 100+3.8%— | 99+6.0%— | — | 98—— | 97—— | 94—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 75—45.5% | 75−1.3%45.5% | 60+33.8%29.5% | 77+103%32.1% | 66+99.3%22.4% | 77+106%22.8% | 45−5.8%12.6% | 38−47.7%9.3% | 33−55.7%7.1% | 37—7.2% | 48—8.3% | 73—11.4% | 75—12.0% | |
| Short-term investments | 63—38.1% | 63−70.5%38.1% | 113−57.0%55.6% | 130−59.1%54.0% | 190−50.0%64.9% | 215−48.9%64.0% | 263−42.4%73.7% | 317−35.3%77.5% | 380−19.8%81.2% | 420—81.4% | 456—79.9% | 490—77.0% | 474—76.3% | |
| Other current assets | 6.6—4.0% | 6.6−28.3%4.0% | 7.3−38.7%3.6% | 8.6−29.2%3.6% | 10−8.7%3.6% | 9.3−23.7%2.8% | 12−27.3%3.3% | 12−37.3%3.0% | 11−32.6%2.4% | 12—2.4% | 16—2.9% | 19—3.0% | 17—2.7% | |
| Current assets | 145—87.7% | 145−51.6%87.7% | 180−43.6%88.8% | 215−41.3%89.6% | 266−37.3%90.9% | 300−36.0%89.6% | 319−38.6%89.6% | 367−36.9%89.8% | 425−24.9%90.7% | 469—91.0% | 520—91.1% | 581—91.5% | 566—91.0% | |
| Property, plant and equipment | 7.7—4.6% | 7.7−39.8%4.6% | 8.9−35.9%4.4% | 9.9−38.7%4.1% | 11−36.8%3.7% | 13−30.2%3.8% | 14−30.3%3.9% | 16−22.2%4.0% | 17−21.6%3.7% | 18—3.5% | 20—3.5% | 21—3.3% | 22—3.5% | |
| Right-of-use (leased) assets | 11—6.4% | 11−33.0%6.4% | 12−31.4%5.7% | 13−33.5%5.3% | 14−31.3%4.7% | 16−23.7%4.7% | 17−27.4%4.8% | 19−21.5%4.7% | 20−20.8%4.3% | 21—4.0% | 23—4.1% | 24—3.8% | 25—4.1% | |
| Total assets | 166—100% | 166−50.6%100% | 203−43.1%100% | 240−41.2%100% | 293−37.4%100% | 335−35.0%100% | 356−37.5%100% | 408−35.8%100% | 468−24.7%100% | 516—100% | 571—100% | 635—100% | 622—100% | |
| Accounts payable | 1.1—0.7% | 1.1−76.0%0.7% | 2.3+3.0%1.1% | 1.4−38.8%0.6% | 1.7−23.7%0.6% | 4.8−5.2%1.4% | 2.2−49.3%0.6% | 2.3−49.3%0.6% | 2.2−41.3%0.5% | 5.0—1.0% | 4.4—0.8% | 4.6—0.7% | 3.8—0.6% | |
| Debt due within a year | 0—0.0% | 0—0.0% | 9.8—4.9% | — | 0.4—0.1% | — | — | — | — | — | — | — | — | |
| Current liabilities | 35—21.4% | 35−55.7%21.4% | 34−59.4%16.9% | 41−62.7%17.1% | 70−44.4%23.7% | 80−43.9%23.8% | 84−42.9%23.7% | 110−33.4%26.9% | 125−29.7%26.7% | 143—27.6% | 148—25.9% | 165—26.0% | 178—28.6% | |
| Long-term debt | 0—0.0% | 0−100%0.0% | 0−100%0.0% | 8.3−12.4%3.5% | 9.3−0.7%3.2% | 9.6—2.9% | 9.5—2.7% | 9.5—2.3% | 9.4—2.0% | — | — | — | 0—0.0% | |
| Lease liabilities (non-current) | 12—7.1% | 12−39.3%7.1% | 14−34.9%6.8% | 16−31.2%6.5% | 17−28.3%6.0% | 19−25.7%5.8% | 21−23.5%5.9% | 23−21.6%5.6% | 24−20.0%5.2% | 26—5.0% | 28—4.8% | 29—4.6% | 30—4.9% | |
| Total liabilities | 49—29.7% | 49−82.3%29.7% | 213−25.4%105% | 230−26.8%95.7% | 263−23.1%89.5% | 278−30.1%82.8% | 285−32.1%80.0% | 314−31.3%76.8% | 342−30.0%72.9% | 397—77.0% | 420—73.6% | 457—71.8% | 488—78.4% | |
| Retained earnings | −893—−539% | −893—−539% | −1,018—−502% | −995—−415% | −972—−331% | −935—−279% | −900—−253% | −870—−213% | −829—−177% | −827—−160% | −785—−138% | −746—−117% | −710—−114% | |
| Shareholders' equity | 117—70.3% | 117+102%70.3% | −10.0−114%−4.9% | 10−89.0%4.3% | 31−75.8%10.5% | 58−51.5%17.2% | 71−52.7%20.0% | 95−47.1%23.2% | 127−5.5%27.1% | 119—23.0% | 151—26.4% | 179—28.2% | 134—21.6% | |
| Total liabilities and equity | 166—100% | 166−50.6%100% | 203−43.1%100% | 240−41.2%100% | 293−37.4%100% | 335−35.0%100% | 356−37.5%100% | 408−35.8%100% | 468−24.7%100% | 516—100% | 571—100% | 635—100% | 622—100% | |
| Shares outstanding | 112—— | 112+4.5%— | 112+10.3%— | 111+11.0%— | 110+11.4%— | 107+9.7%— | 101+4.0%— | 100+3.7%— | 99+16.7%— | 98—— | 97—— | 96—— | 85—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 4.3−26.1%2.5% | 1.0*−20.7%0.6% | 1.0*−55.0%31.6% | 1.1+9.9%103% | 1.2*−6.0%18.7% | 1.2*−6.1%37.9% | 2.3*+65.9%29.6% | 1.0−31.8%26.6% | 1.2*−13.6%2.3% | 1.3*—8.6% | 1.4*—9.3% | 1.4—9.1% | 1.4*—9.5% | |
| Share-based compensation | 12−61.4%7.1% | 2.0−68.8%1.2% | 2.6−63.0%78.6% | 2.9−65.2%278% | 4.8*−52.6%77.6% | 6.4−29.1%196% | 7.1−28.7%89.7% | 8.4−19.0%226% | 10*−11.5%18.8% | 9.0—58.9% | 9.9—65.7% | 10—64.8% | 12*—76.0% | |
| Cash from operating activities | −150—−86.4% | −24*—−14.8% | −34*—−1031% | −50—−4762% | −42*—−668% | −33*—−997% | −49*—−623% | −61—−1643% | −55*—−101% | −51*—−331% | −63*—−416% | −61—−386% | −46*—−303% | |
| Capital expenditure | −0.1—−0.1% | 0*—0.0% | −0.0*—−0.9% | −0.1—−11.3% | 0*—0.0% | −0.0*—−0.3% | −0.0*—−0.1% | −0.0—−0.5% | −0.2*—−0.3% | −0.2*—−1.4% | −0.3*—−2.2% | −0.5—−3.4% | −0.2*—−1.5% | |
| Cash from investing activities | 154−27.6%88.6% | 50*+1.1%30.8% | 17*−69.3%516% | 61−7.3%5827% | 26*−38.2%410% | 50*+22.8%1520% | 56*+50.0%708% | 66—1777% | 41*+129%76.3% | 40*—263% | 37*—246% | −12—−74.0% | 18*—119% | |
| Shares issued | — | — | — | — | 5.3*—84.7% | — | — | — | 0*—0.0% | — | — | — | — | |
| Cash from financing activities | −4.9−120%−2.8% | −10*−171%−6.4% | 0.1*−59.0%1.5% | 0.0—2.4% | 5.4*−44.9%86.5% | 15*—451% | 0.1*−81.1%1.5% | 0−100%0.0% | 9.8*+1559%18.0% | 0*—0.0% | 0.6*—4.3% | 71—447% | 0.6*—3.9% | |
| Change in cash | −1.0−103%−0.6% | 16*−51.0%9.6% | −17*−351%−513% | 11+125%1067% | −11*—−172% | 32*—973% | 6.8*—86.3% | 5.0—134% | −3.8*—−7.1% | −10*—−67.7% | −25*—−166% | −2.0—−12.6% | −27*—−180% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Executive pay at Alector, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Arnon Rosenthal, Ph.D | $2.0 M | $1.9 M | $1.3 M | $17 (peers $135) |
| 2024Arnon Rosenthal | $3.7 M | −$1.8 M | $1.9 M | $20 (peers $102) |
| 2023Arnon Rosenthal | $4.3 M | $3.2 M | $2.0 M | $86 (peers $104) |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Alector, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Restructuring 3 · Directors and officers 5 · Material agreement 4 · Agreement ended 1 · New debt 1 · Shareholder vote 3 · Results announced 13
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Material agreementResults announced | 8-K | |
| Results announced | 8-K | |
| Agreement ended | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| RestructuringDirectors and officersResults announced | 8-K | |
| Results announced | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Restructuring | 8-K | |
| Results announced | 8-K | |
| Restructuring | 8-K | |
| Material agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 5, 2026
Acquisitions and funding#
1 private funding rounds before listing
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2015 | $32 M | No. 1 | $10 to $50 million | 11 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | · | · | 25 | · | · | · | · | · | · | 75 | · | · | 100 |
| 2024 | · | · | · | · | · | · | · | · | · | · | 41 | · | 41 |
| 2023 | · | · | 30 | · | · | · | · | · | · | · | · | · | 30 |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| effective | 75 people | LayoffWARN notice | South San Francisco, California | Notice list |
| 75 people | Restructuring planSEC 8-K | “The Company initiated a reduction in force impacting approximately 75 employees across the organization.” | Filing | |
| 25 people | Restructuring planSEC 8-K | “The Company initiated a reduction in force impacting approximately 25 employees across the organization.” | Filing | |
| 41 people | Restructuring planSEC 8-K | “The Company initiated a reduction in force impacting approximately 41 employees across the organization.” | Filing | |
| 30 people | Restructuring planSEC 8-K | “The Company initiated a reduction in force impacting approximately 30 employees across the organization effective March 29, 2023.” | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Alector, Inc. compares in Biotechnology
- Market cap$293 M · higher than 51% of 726
- Revenue growth3.6% · higher than 48% of 438
- Price / book9.6× · lower than 16% of 534
- FCF yield-62.8% · higher than 19% of 449
- 🇺🇸 SAB Biotherapeutics, Inc.$291 M
- 🇺🇸 Vogenx, Inc.$296 M
- 🇺🇸 Eikon Therapeutics, Inc.$290 M
- 🇮🇪 Amarin Corporation$297 M
- 🇺🇸 Agenus Inc.$290 M
- 🇩🇪 InflaRx N.V.$301 M
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Alector, Inc.🇺🇸 | $293 M | — | — | +3.6% |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M
- Arvinas, Inc.$544 M
Sources and freshness
- Market cap:
- Oct 21, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As on 2021
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Alector, Inc.? Verify and update this profile — free
Show Alector, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.